| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.0048 | 1 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.00077 | 1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.0036 | 1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.00069 | 1 |